Lawmakers on the first congressional panel to conduct a hearing on the Toyota recalls, the House Energy and Commerce Committee's Subcommittee on Oversight and Investigations, have Toyota connections in their districts - or their garages. Other members have different car connections. ...more

February 24, 2010

Handing President Barack Obama a hard-fought victory, the House narrowly approved a sweeping overhaul of the nation's health care system Saturday, advancing legislation that the Democrats said could be their defining social policy achievement. ...more

November 8, 2009

The Democratic-controlled House has passed historic health care legislation to provide medical coverage to millions more Americans. ...more

November 7, 2009

Are you keeping up with the latest from Washington? ...more

February 13, 2009

Rep. Henry Waxman - a liberal ally of Speaker Nancy Pelosi - has wrested the chairmanship of the powerful House Energy and Commerce Committee from veteran Rep. John Dingell when the new Congress convenes in January. ...more

November 20, 2008

In regards to Dallas Dunlap's letter in this past Sunday's edition, I beg to differ in one respect to his letter: Environmentalists have played a major role in a current energy crisis situation. ...more

June 4, 2008

When "diet and exercise isn't enough," Pfizer still wants consumers to ask their doctor about Lipitor - just not Robert Jarvik. ...more

February 26, 2008

The U.S. Food and Drug Administration published guidelines that suggest employees of fresh-cut fruit and vegetable processors wash their hands to help stop the spread of contamination. ...more

February 23, 2008

A U.S. economic aid program to keep Russian scientists from selling weapons information to terrorists apparently funneled much of the money to scientists who never claimed to have a background in nuclear, chemical or biological programs, a congressional report said Friday. ...more

January 12, 2008

On Dec. 13, a trio of bipartisan U.S. congressmen penned a letter calling for an investigation into the Food and Drug Administration's handling recently of a drug that was being considered for terminal prostate cancer patients. ...more

December 26, 2007